Jiuzhitang Valuation

Q: What is the Fair Price of 000989 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

000989 (CN¥6.98) is trading above our estimate of [[fair value]] (CN¥4.96)

Is 000989 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 000989 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 000989 (CN¥6.98) is trading above our estimate of fair value (CN¥4.96)

Significantly Below Fair Value: 000989 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 000989?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 000989. This is calculated by dividing 000989's market cap by their current preferred multiple.
What is 000989's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥5.91b

000989 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2x
Enterprise Value/EBITDA	18.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 000989's PE Ratio compare to its peers?

The above table shows the PE ratio for 000989 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	58.1x
000813 Dezhan Healthcare	59.6x	n/a	CN¥6.0b
002907 Chongqing Pharscin Pharmaceutical	126.3x	n/a	CN¥5.2b
688526 Wuhan Keqian BiologyLtd	20.3x	25.0%	CN¥5.9b
002390 Guizhou Xinbang Pharmaceutical	26.2x	n/a	CN¥6.4b
000989 Jiuzhitang	23x	n/a	CN¥5.9b

Price-To-Earnings vs Peers: 000989 is good value based on its Price-To-Earnings Ratio (23x) compared to the peer average (58.1x).

Price to Earnings Ratio vs Industry

How does 000989's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 000989 is good value based on its Price-To-Earnings Ratio (23x) compared to the CN Pharmaceuticals industry average (26.4x).

Price to Earnings Ratio vs Fair Ratio

What is 000989's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

000989 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	23x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 000989's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.